European Pharmaceutical Review: Pushing Doctors To Prescribe Cholesterol-Lowering Statins Triples Prescription Rate

“A clinical trial ‘nudging’ doctors led to three times the number of statins prescribed. The study, by Penn Medicine researchers, used an online dashboard using two ‘nudges’; one a peer comparison feedback providing physicians with information on their performance relative to other physicians, and the other an active choice framing to prompt physicians to make a decision on prescriptions. Atorvastatin and simvastatin are two of many cholesterol-lowering statins known to prevent heart attack, strokes and associated deaths. These drugs are relatively inexpensive, with minor side effects. Estimates suggest tens of millions more people should be taking these drugs.” Read more at European Pharmaceutical Review